440 related articles for article (PubMed ID: 11588264)
1. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.
Pennacchio LA; Olivier M; Hubacek JA; Cohen JC; Cox DR; Fruchart JC; Krauss RM; Rubin EM
Science; 2001 Oct; 294(5540):169-73. PubMed ID: 11588264
[TBL] [Abstract][Full Text] [Related]
2. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
[TBL] [Abstract][Full Text] [Related]
3. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
4. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice.
Baroukh N; Bauge E; Akiyama J; Chang J; Afzal V; Fruchart JC; Rubin EM; Fruchart-Najib J; Pennacchio LA
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1297-302. PubMed ID: 15117734
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5.
Fruchart-Najib J; Baugé E; Niculescu LS; Pham T; Thomas B; Rommens C; Majd Z; Brewer B; Pennacchio LA; Fruchart JC
Biochem Biophys Res Commun; 2004 Jun; 319(2):397-404. PubMed ID: 15178420
[TBL] [Abstract][Full Text] [Related]
6. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
7. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
van Dijk KW; Rensen PC; Voshol PJ; Havekes LM
Curr Opin Lipidol; 2004 Jun; 15(3):239-46. PubMed ID: 15166778
[TBL] [Abstract][Full Text] [Related]
8. The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice.
Gao J; Wei Y; Huang Y; Liu D; Liu G; Wu M; Wu L; Zhang Q; Zhang Z; Zhang R; Liang C
J Biol Chem; 2005 Apr; 280(13):12559-66. PubMed ID: 15649902
[TBL] [Abstract][Full Text] [Related]
9. [Apolipoprotein AV and triglyceridemia].
Hubácek JA
Cas Lek Cesk; 2004; 143(12):799-803. PubMed ID: 15730209
[TBL] [Abstract][Full Text] [Related]
10. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.
Pennacchio LA; Rubin EM
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):529-34. PubMed ID: 12615678
[TBL] [Abstract][Full Text] [Related]
12. The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction.
Hubacek JA; Skodová Z; Adámková V; Lánská V; Poledne R
Clin Genet; 2004 Feb; 65(2):126-30. PubMed ID: 14984471
[TBL] [Abstract][Full Text] [Related]
13. Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.
Talmud PJ
Atherosclerosis; 2007 Oct; 194(2):287-92. PubMed ID: 17222847
[TBL] [Abstract][Full Text] [Related]
14. APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men.
Baum L; Tomlinson B; Thomas GN
Clin Genet; 2003 May; 63(5):377-9. PubMed ID: 12752569
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of human APOA5 haplotypes.
Ahituv N; Akiyama J; Chapman-Helleboid A; Fruchart J; Pennacchio LA
Genomics; 2007 Dec; 90(6):674-9. PubMed ID: 17936576
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of APOAV polymorphisms (T-1131/C, Ser19/Trp and Val153/Met): no effect on plasma remnant particles concentrations.
Hubacek JA; Kovár J; Skodová Z; Pit'ha J; Lánská V; Poledne R
Clin Chim Acta; 2004 Oct; 348(1-2):171-5. PubMed ID: 15369751
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
[TBL] [Abstract][Full Text] [Related]
18. Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons.
Wang QF; Liu X; O'Connell J; Peng Z; Krauss RM; Rainwater DL; VandeBerg JL; Rubin EM; Cheng JF; Pennacchio LA
Hum Mol Genet; 2004 May; 13(10):1049-56. PubMed ID: 15044382
[TBL] [Abstract][Full Text] [Related]
19. The apolipoprotein CIII enhancer regulates both extensive histone modification and intergenic transcription of human apolipoprotein AI/CIII/AIV genes but not apolipoprotein AV.
Li YJ; Wei YS; Fu XH; Hao DL; Xue Z; Gong H; Zhang ZQ; Liu DP; Liang CC
J Biol Chem; 2008 Oct; 283(42):28436-44. PubMed ID: 18678879
[TBL] [Abstract][Full Text] [Related]
20. The apolipoprotein AV gene and diurnal triglyceridaemia in normolipidaemic subjects.
Masana L; Ribalta J; Salazar J; Fernández-Ballart J; Joven J; Cabezas MC
Clin Chem Lab Med; 2003 Apr; 41(4):517-21. PubMed ID: 12747596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
